Checkpoint Capital L.P.
CIK
1977548
Location
SAN FRANCISCO, CA
Portfolio Value
Small
$278,650,517
Diversification
Highly concentrated
Filing Date
Global Rank
#3,220
/ 8,232
▼ 40
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
+5.1%
Period ended 2 months ago
Filed May 15, 2026 · 29d
10 quarters · since Dec 2023
Clone Performance
Feb 2024–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+68.4%
SPY
+52.9%
Annualised alpha
+5.1%
Max drawdown
−28.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
8 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
40.1%
+2.8 pts
Top 5
98.4%
+1.7 pts
Top 10
100.0%
0.0 pts
HHI
3,221
Highly concentrated+473
Portfolio Trend
10 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $278,650,517 |
Last Quarter's Activity
Export CSVSold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 529,695 | $18,433,386 | |
| No positions match the current search. | ||||
8 positions ·
$278,650,517 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ARGX |
Argenx SE
Healthcare
|
Added | 153,000 | $111,728,250 | 40.10% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Added | 1,227,200 | $106,729,584 | 38.30% | |
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 262,539 | $25,531,917 | 9.16% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Reduced | 286,661 | $18,329,104 | 6.58% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 180,000 | $11,863,800 | 4.26% | |
| SEPN |
Septerna, Inc.
Healthcare
|
NEW | 100,300 | $2,410,209 | 0.86% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
NEW | 40,230 | $1,461,153 | 0.52% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
NEW | 50,000 | $596,500 | 0.21% |